Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin BID vs TID for CAP in Children
NCT03031210Phase 3Recruiting
- Sponsor
- Centre Hospitalier Universitaire Sainte-Justine
- Start
- Jun 2017
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of amoxicillin in community acquired pneumonia (CAP) (2 arms), sponsored by Centre Hospitalier Universitaire Sainte-Justine. Primary endpoint: Treatment failure within 10 days of enrolment. Started Jun 2017; status: recruiting.
02
Drugs
amoxicillin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT03031210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03031210.